Correlation Between CITIUS PHARMAC and Nucletron Electronic

Can any of the company-specific risk be diversified away by investing in both CITIUS PHARMAC and Nucletron Electronic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CITIUS PHARMAC and Nucletron Electronic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CITIUS PHARMAC DL and Nucletron Electronic Aktiengesellschaft, you can compare the effects of market volatilities on CITIUS PHARMAC and Nucletron Electronic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CITIUS PHARMAC with a short position of Nucletron Electronic. Check out your portfolio center. Please also check ongoing floating volatility patterns of CITIUS PHARMAC and Nucletron Electronic.

Diversification Opportunities for CITIUS PHARMAC and Nucletron Electronic

0.0

Correlation Coefficient

CITIUS PHARMAC  Nucletron Electronic

Pay attention - limited upside

The 3 months correlation between CITIUS and Nucletron is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding CITIUS PHARMAC DL and Nucletron Electronic Aktienges in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nucletron Electronic and CITIUS PHARMAC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CITIUS PHARMAC DL are associated (or correlated) with Nucletron Electronic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nucletron Electronic has no effect on the direction of CITIUS PHARMAC i.e., CITIUS PHARMAC and Nucletron Electronic go up and down completely randomly.

Pair Corralation between CITIUS PHARMAC and Nucletron Electronic

If you would invest  760.00  in Nucletron Electronic Aktiengesellschaft on September 16, 2024 and sell it today you would earn a total of  0.00  from holding Nucletron Electronic Aktiengesellschaft or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CITIUS PHARMAC DL  vs.  Nucletron Electronic Aktienges

CITIUS PHARMAC DL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CITIUS PHARMAC DL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Nucletron Electronic

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nucletron Electronic Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Nucletron Electronic is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with CITIUS PHARMAC and Nucletron Electronic

The main advantage of trading using opposite CITIUS PHARMAC and Nucletron Electronic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CITIUS PHARMAC position performs unexpectedly, Nucletron Electronic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nucletron Electronic will offset losses from the drop in Nucletron Electronic's long position.

The idea behind CITIUS PHARMAC DL and Nucletron Electronic Aktiengesellschaft pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.